Kelley-Ross & Associates, Inc. dba Kelley-Ross Compounding Pharmacy

Warning LetterClosed

United StatesFEI 3013436443Issued Jul 30, 2018

View FDA's record for FEI 3013436443

Source: FDA warning letter records. FDA has not published the text of this letter. To check it, open FDA's record for this establishment, listed under FEI 3013436443.

Violations0

Issue DateJul 30, 2018

Product TypeOther

StatusClosed

Letter Details

Firm: Kelley-Ross & Associates, Inc. dba Kelley-Ross Compounding Pharmacy
Location: United States
FEI Number: 3013436443
Country: United States
Issue Date: July 30, 2018
Issuing Office: N/A
Product Type: Other
Status: Closed

Summary

Based on limited metadata, this warning letter was issued to Kelley-Ross Compounding Pharmacy, a pharmaceutical compounding operation, on July 30, 2018. While the specific violations cannot be detailed due to unavailable subject line information, the letter represents FDA enforcement action against a compounding pharmacy, which typically involves concerns related to preparation, quality, sterility, or distribution practices of compounded medications. The exact regulatory basis and specific violations addressed in this letter cannot be determined from the metadata provided.

Kelley-Ross & Associates, Inc. dba Kelley-Ross Compounding Pharmacy FDA Warning Letter, July 30, 2018